Range Low Price High Price Comment
30 days $27.00 $36.72 Thursday, 28th Mar 2024 ARWR stock ended at $28.60. This is 0.348% less than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 3.44% from a day low at $28.10 to a day high of $29.07.
90 days $27.00 $39.83
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
2021-07-21 $67.92 $68.75 $65.97 $68.08 520 909
2021-07-20 $65.66 $68.11 $65.51 $67.91 902 102
2021-07-19 $62.35 $66.15 $62.11 $65.55 854 397
2021-07-16 $63.73 $64.60 $62.26 $63.43 516 707
2021-07-15 $62.56 $63.34 $61.59 $63.15 478 311
2021-07-14 $63.92 $63.92 $61.69 $62.54 732 091
2021-07-13 $65.01 $65.60 $63.32 $63.41 560 928
2021-07-12 $67.14 $68.73 $65.64 $65.78 491 642
2021-07-09 $65.81 $67.46 $64.73 $67.14 792 958
2021-07-08 $62.35 $66.01 $61.51 $65.32 923 105
2021-07-07 $62.68 $64.31 $61.53 $63.73 1 516 640
2021-07-06 $65.01 $67.44 $62.19 $63.07 2 693 105
2021-07-02 $67.04 $69.25 $60.00 $63.13 7 337 609
2021-07-01 $82.71 $86.01 $82.20 $84.96 685 469
2021-06-30 $81.01 $84.31 $81.00 $82.82 639 045
2021-06-29 $86.00 $86.48 $81.47 $81.50 1 101 058
2021-06-28 $89.41 $91.00 $85.93 $86.22 767 316
2021-06-25 $89.34 $90.44 $88.30 $90.32 1 631 668
2021-06-24 $88.69 $90.41 $88.48 $89.51 704 957
2021-06-23 $90.00 $93.66 $87.35 $88.09 1 022 383
2021-06-22 $89.22 $89.63 $87.52 $88.83 723 246
2021-06-21 $85.94 $90.60 $85.81 $89.81 856 472
2021-06-18 $85.03 $86.71 $84.51 $85.64 1 264 630
2021-06-17 $85.44 $86.93 $84.93 $85.98 532 705
2021-06-16 $86.65 $87.36 $83.89 $85.84 622 725
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT